Nabriva Therapeutics Plc Total Liabilities

Nabriva Therapeutics Plc (NBRV) currently reports a total liabilities of $29M as of March 2023. That compares with $21M in the prior-year period — up 35.6% year over year. Use the charts on this page to explore Nabriva Therapeutics Plc's total liabilities history and peer comparisons.

Nabriva Therapeutics Plc's total liabilities increased from $21M to $29M — a 35.6% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nabriva Therapeutics Plc reported $29M in total liabilities as of March 2023. That compares with $21M in the prior-year period — up 35.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $29M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nabriva Therapeutics Plc, and consider following NBRV for alerts when major investors trade the stock.

Nabriva Therapeutics Plc is classified in the Healthcare sector. On total liabilities, it currently shows $29M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NBRV with unrelated industries.